Chris Buyse
Managing Partner
General sciences
Pfizer
Belgium
Biography
Chris Buyse was CFO at ThromboGenics NV from September 2006 until June 2014. He has 25 years of experience in international company finance and in running and establishing best financial practice. He was previously CFO of the Belgian biotechnology company CropDesign. Before this, he was Finance Director of WorldCom/MCI Belux, and was CFO and interim CEO of Keyware Technologies, in addition, he held several financial positions at Suez Lyonnaise des Eaux and Unilever. He is currently serving as an independent Board Member of a few companies, mostly active in life sciences such as Celyad, Bone Therapeutics, Iteos and Bioxodes.
Research Interest
General sciences
